Loading...
Loading...
Little old Betaville has a feeling dealmaking in the US-listed biotechnology space may be about to break out after Bloomberg unveiled a corking scoop about how Denmark's Novo Nordisk has made rival offer for US-listed Metsera, which agreed to a $4.9 billion takeover from Pfizer earlier this summer.
It's a bit of a merger Monday in the US, with three major deals announced today.
The venerable Financial Times has landed a corking biotech scoop on a Monday morning.